About Oculeve
Oculeve is a company based in San Francisco (United States) founded in 2011. Oculeve has raised $24.94 million across 4 funding rounds from investors including Kleiner Perkins, NEA and Versant Ventures. The company has 19 employees as of December 31, 2015. Oculeve operates in a competitive market with competitors including TearScience, Tear Film Innovations, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others.
- Headquarter San Francisco, United States
- Employees 19 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oculeve, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.94 M (USD)
in 4 rounds
-
Latest Funding Round
$16.65 M (USD), Series B
Mar 18, 2014
-
Investors
Kleiner Perkins
& 3 more
-
Employee Count
19
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oculeve
Oculeve has successfully raised a total of $24.94M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16.65 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oculeve
Oculeve has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, NEA and Versant Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for Oculeve
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oculeve
Investment portfolio details for Oculeve
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oculeve
Detailed financials for Oculeve
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oculeve Comparisons
Peer comparison for Oculeve
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oculeve
Oculeve operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TearScience, Tear Film Innovations, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for evaporative dry eye diagnosis and treatment are developed.
|
|
| Locked | Locked | Locked |
Evaporative dry eye is treated through meibomian gland stimulation devices.
|
|
| Locked | Locked | Locked |
Solutions for dry eye and pain management are developed.
|
|
| Locked | Locked | Locked |
Provider and developer of tear production device for treatments of dry eye disease
|
|
| Locked | Locked | Locked |
Offers lacrimal stents and procedures designed to effectively treat sinusitis.
|
Detailed competitors of Oculeve
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oculeve
Complete news archive for Oculeve
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oculeve
Oculeve was founded in 2011.
Oculeve is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Oculeve is a funded company, having raised a total of $24.94M across 4 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Oculeve is 19.
Oculeve is developing a treatment for dry eye disease. Its technology was conceptualized at Stanford University in a collaboration between the Departments of Biodesign and Ophthalmology. Its lead product is a non-invasive nasal neurostimulation device that increases tear production in patients with dry eye disease. The company was acquired by Allergan in July 2015 for a 125M upfront payment and milestone payments related to its lead development program.
Oculeve's top competitors include Tear Film Innovations, TearScience and Bruder Healthcare.
Oculeve has 4 investors. Key investors include Kleiner Perkins, NEA, Versant Ventures, and Stanford Biodesign.